Guggenheim Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,849
| Closed | -$207K | – | 2063 |
|
|
2022
Q4 | $207K | Buy |
+13,849
| New | +$207K | ﹤0.01% | 1799 |
|
|
2018
Q2 | – | Sell |
-2,581
| Closed | -$75K | – | 2732 |
|
|
2018
Q1 | $75K | Buy |
2,581
+287
| +13% | +$8.34K | ﹤0.01% | 2677 |
|
|
2017
Q4 | $64K | Buy |
2,294
+230
| +11% | +$6.42K | ﹤0.01% | 2625 |
|
|
2017
Q3 | $75K | Buy |
2,064
+14
| +0.7% | +$509 | ﹤0.01% | 2668 |
|
|
2017
Q2 | $46K | Hold |
2,050
| – | – | ﹤0.01% | 2741 |
|
|
2017
Q1 | $12K | Buy |
2,050
+205
| +11% | +$1.2K | ﹤0.01% | 2810 |
|
|
2016
Q4 | $10K | Hold |
1,845
| – | – | ﹤0.01% | 2882 |
|
|
2016
Q3 | $16K | Sell |
1,845
-14
| -0.8% | -$121 | ﹤0.01% | 2842 |
|
|
2016
Q2 | $18K | Hold |
1,859
| – | – | ﹤0.01% | 2817 |
|
|
2016
Q1 | $17K | Buy |
1,859
+535
| +40% | +$4.89K | ﹤0.01% | 2836 |
|
|
2015
Q4 | $17K | Hold |
1,324
| – | – | ﹤0.01% | 2929 |
|
|
2015
Q3 | $16K | Buy |
1,324
+165
| +14% | +$1.99K | ﹤0.01% | 2909 |
|
|
2015
Q2 | $20K | Hold |
1,159
| – | – | ﹤0.01% | 2995 |
|
|
2015
Q1 | $17K | Buy |
1,159
+145
| +14% | +$2.13K | ﹤0.01% | 2999 |
|
|
2014
Q4 | $9K | Buy |
+1,014
| New | +$9K | ﹤0.01% | 2983 |
|
|
2014
Q3 | – | Sell |
-2,298
| Closed | -$42K | – | 3114 |
|
|
2014
Q2 | $42K | Sell |
2,298
-991
| -30% | -$18.1K | ﹤0.01% | 3054 |
|
|
2014
Q1 | $49K | Buy |
3,289
+2,168
| +193% | +$32.3K | ﹤0.01% | 3079 |
|
|
2013
Q4 | $21K | Buy |
+1,121
| New | +$21K | ﹤0.01% | 3067 |
|